Cloudpharm’s latest study (DOI: https://pubs.acs.org/doi/10.1021/acs.jcim.5c02286) presents a computational framework for predicting the environmental impact of pharmaceuticals on aquatic life. Using high-performing machine learning models, the study predicts both...
s vythoulkas
Dr. Ying’s 3-month FRUITPRINT WP2 Secondment Was Completed
A first key milestone in CLOUDPHARM’s contribution to FRUITPRINT’s knowledge-sharing objectives was achieved on 20 December, with the successful completion of a three-month secondment hosted at our premises by brilliant INP-GBF plant researcher Dr. Shiyu Ying. During...
Successful Completion of EU HORIZON-Funded “ENVIROMED” Project
As of 30 November 2025, Cloudpharm and its partners have successfully completed the Horizon Europe–funded project ENVIROMED. The project represents a key contribution to the EU Green Deal, having developed innovative technologies that enable greener and more efficient...
Cloudpharm Attended InnoDays 2025 in Crete
Cloudpharm attended InnoDays 2025, connecting with fellow Greek leading researchers and innovators. The event provided an inspiring platform to exchange ideas, explore cutting-edge scientific developments, and expand our network of collaborations. These interactions...
ENVIROMED’s 6th Plenary Meeting Participation
The Cloudpharm team participated in the 6th ENVIROMED Plenary Meeting in Kea Island, Greece in June 18-19 2025. Project progress was communicated through engagement with fellow researchers. The meeting provided an excellent opportunity to exchange ideas, discuss...
Cloudpharm Attended Vitafoods 2025 in Barcelona
Cloudpharm was present at Vitafoods 2025 in Barcelona, exploring the latest trends in ingredients, delivery systems and supplement formats. The visit provided valuable insights into the state-of-the-art of emerging biotechnological companies, ensuring that our...